Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate. [electronic resource]
- Experimental & molecular medicine Jul 2002
- 211-23 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1226-3613
10.1038/emm.2002.30 doi
Binding, Competitive Catalytic Domain Crystallography, X-Ray Dose-Response Relationship, Drug Drug Evaluation, Preclinical Edetic Acid--pharmacology Enzyme Inhibitors--pharmacology Humans Inhibitory Concentration 50 Kinetics Models, Molecular Molybdenum--pharmacology Phosphoric Acids--pharmacology Protein Structure, Tertiary Protein Tyrosine Phosphatases--antagonists & inhibitors Substrate Specificity Tungsten Compounds--pharmacology